Market Overview

Piper Jaffray Initiates Coverage on Inovio Pharmaceuticals, Inc. at Overweight, Announces $1.00 PT

Get News First. Profit Faster

upsell-button
With Benzinga Professional get unlimited access to ALL content! PLUS:
  • REALTIME NEWSFEED
  • REALTIME AUDIO NEWS
  • FULL CALENDAR SUITE
  • CHAT WITH OUR NEWS DESK

Latest Ratings for INO

DateFirmActionFromTo
Jul 2014Aegis CapitalUpgradesHoldBuy
May 2014Stifel NicolausInitiates Coverage onBuy
Nov 2013Aegis CapitalReiteratesHold

View More Analyst Ratings for INO
View the Latest Analyst Ratings

Posted-In: News Analyst Ratings

 

Related Articles (INO)

Around the Web, We're Loving...

Partner Network

Get Benzinga's Newsletters